Multidisciplinary Update in Breast Disease 2024
This course offers Live (in-person) and Livestream (virtual) attendance options
Course Directors: Pooja P. Advani, M.B.B.S., M.D., Patricia A. Cronin, M.D., James W. Jakub, M.D., and Sandhya Pruthi, M.D.
November 6 - 9, 2024 - Hilton La Jolla Torrey Pines - La Jolla, California
This three-and-a-half-day continuing medical education course provides a multidisciplinary update in prevention, evaluation, diagnosis, management, and treatment of benign and malignant breast diseases, and high risk and survivorship issues. The course has multidisciplinary experts in their field presenting the latest, diagnostic, treatment and management options. Highlights include, genetics and high-risk management, breast imaging modalities, supplemental screening options for dense breasts, and more.
Target Audience
This course is designed for primary care providers, oncologists, radiologists, surgeons, pathologists, gynecologists, and advanced practice providers who diagnose and treat patients with breast cancer.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe breast cancer risk stratification
- Identify management options for lobular neoplasia
- Recognize oncoplastic surgical options
- Summarize current breast cancer challenges in disparate populations
- Review updates in the management of early breast cancer
- Describe menopausal hormone therapy in breast cancer survivors
- Review surveillance imaging in high-risk breast lesions
- Summarize multidisciplinary management of metastatic breast cancer
- Recognize role of minimally invasive surgery
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
Multidisciplinary Update in Breast Disease 2024
November 6-9, 2024 Hilton La Jolla Torrey Pines La Jolla, CA
All Times in Pacific Standard Time Zone (UTC -8)
All talks include 5 minutes of questions
Wednesday, November 6, 2024
4:00 p.m. | Pre-Course Session Registration |
4:15 | Digital Healthcare for Breast Cancer Survivors Daniela Stan, MD (MCR) |
4:45 | Artificial Intelligence in Pathology Saba Yasir, MBBS (MCR) |
5:15 | Dinner |
5:30 | Quantitative High-Definition Microvasculature Imaging for Cancer Diagnosis Azra Alizad, MD (MCR) |
6:00 | Emerging Role of New PET Tracers for Management of Breast Cancer Ephraim Parent, MD, PhD (MCF) |
6:30 | ER and Her2Neu Tumor Plasticity Pooja Advani, MBBS, MD & Saba Yasir, MBBS |
7:00 | Ultrasound Twinkling Detection of Breast Biopsy Markers Christine Lee, MD, PhD (MCR) |
7:30 p.m. | Adjourn |
Thursday, November 7, 2024
7:30 a.m. | Registration and Breakfast / Exhibit Hall |
7:50 | Welcome and Introductions |
8:00 | Lobular Neoplasia Julie Billar, MD (MCA) |
8:30 | Breast Pain: Surgical Mariah Koenen, PA-C (MCSWW) |
9:00 | Breast Pain: Medical Shana Salik, APRN, CNP, MSN (MCR) |
9:30 | Breast Cancer Risk Stratification and Risk Reducing Strategies Sandhya Pruthi, MD (MCR) |
10:00 | Menopausal Hormone Therapy in Breast Cancer Survivors Daniela Stan, MD (MCR) |
10:30 | Break / Exhibit Hall |
10:45 | Ordering Multigene Panel Testing from a Genetic Counselor Perspective Laura Ongie, MS, CGC (MCR) |
11:15 | The Red Breast: Differential Diagnosis and Management Jessie Fraker, MD (MCR) |
11:45 | Supplemental Imaging: MRI vs MBI vs CEM vs ABUS Christine Lee, MD, PhD (MCR) |
12:15 p.m. | Lunch / Exhibit Hall |
1:15 | Surveillance Imaging for High-Risk Breast Lesions Christine Klassen, MD (MCR) |
1:45 | Lifestyle Strategies to Reduce Breast Cancer Risk and Combat Obesity Dawn Mussallem, DO (MCF) |
2:15 | Nipple Discharge: Diagnostic Evaluation and Management Jessie Fraker, MD (MCR) |
2:45 | Break / Exhibit Hall |
3:00 | Workshop 1 – Mutation Carriers Workshop Christine Klassen, MD; Mariah Koenen, PA-C; Laura Ongie, MS, CGC; Patricia Cronin, MD |
3:30 | Workshop 2 – High Risk Assessment Workshop Sandhya Pruthi, MD; Jessie Fraker, MD; Shana Salik, APRN, CNP, MSN; Kristin Robinson, MD |
4:00 p.m. | Adjourn |
Friday, November 8, 2024
7:00 a.m. | Breakfast / Exhibit Hall |
7:30 | Intraoperative Specimen Margin Assessment Julie Billar, MD (MCA) |
8:00 | Current Breast Cancer Challenges in Disparate Population Shon Black, MD (MCR) |
8:30 | Optimum Screening for Breast Cancer Survivors Kristin Robinson, MD (MCF) |
9:00 | Break / Exhibit Hall |
9:15 | Exceptional Responders: Surgeon’s Perspective James Jakub, MD (MCF) |
9:45 | How to Prevent and Treat Radiation Complications Kimberly Corbin, MD (MCR) |
10:15 | BCT: Less is More Patricia Cronin, MD (MCA) |
10:45 | Break / Exhibit Hall |
11:00 | Is it Time to Omit SLNB in Early Invasive Breast Cancers? Shon Black, MD (MCR) |
11:30 | Neoadjuvant Radiation Sarah James, MD, PhD (MCA) |
12:00 p.m. | What’s New in Oncoplastic Surgery? Kunle Elegbede, MD, PhD (MCF) |
12:30 | Lunch / Exhibit Hall |
1:30 | Workshop 1 – Management of the Axila Workshop James Jakub, MD; Patricia Cronin, MD; Kimberly Corbin, MD; Sarah James, MD, PhD; Pooja Advani, MBBS, MD; Christine Lee, MD, PhD; Kunle Elegbede, MD, PhD |
2:30 p.m. | Adjourn |
Saturday, November 9, 2024
7:00 a.m. | Breakfast / Exhibit Hall |
7:30 | Liquid Biopsy in the Current Management of BC? Karthik Giridhar, MD (MCR) |
8:00 | Updates in the Management of Early Breast Cancer Brenda Ernst, MD (MCA) |
8:30 | Optimal Adjuvant Endocrine Therapy Duration and Bisphosphonate Use Rohit Rao, MBBS, MD (MCF) |
9:00 | Is Anyone Really HER2 Negative? Advances in Targeting HER2 Low BC Karthik Giridhar, MD (MCR) |
9:30 | Break / Exhibit Hall |
9:45 | Breast Cancer in Premenopausal Women: Biology and Clinical Management Brenda Ernst, MD (MCA) |
10:15 | Metastasis Directed Therapy in BC: Are We Ready? Charles Ritchie, MD (MCF) |
10:45 | Side Effects of Newer Breast Cancer Therapies Rohit Rao, MBBS, MD (MCF) |
11:15 | Case-Based Panel Discussion Pooja Advani, MBBS, MD; Charles Ritchie, MD; Brenda Ernst, MD; Karthik Giridhar, MD; James Jakub, MD; Kimberly Corbin, MD |
12:00 p.m. | Adjourn |
Program subject to change without notice
Reservations on the contracted hotel block are available to faculty, enrolled attendees and confirmed exhibitors for the in-person general session only. Due to limited availability, we request only one room reserved per attendee/exhibit booth at this time. You will receive the booking link via email within 30 minutes of enrolling. Please be sure to check your spam folder if not received in your inbox.
The Hilton La Jolla Torrey Pines is offering hotel rooms for attendees beginning at the group rate of $269 per night plus applicable taxes and an optional resort fee of $32/night. In order to receive the special rate, reservations must be made online via a provided link. Reservations must be made by Tuesday, October 1, 2024 or before the room block is filled, whichever comes first. There is limited guest room availability at the special rate; early reservations are encouraged. Please contact the hotel for their cancellation policy. Attendees are responsible for their own reservations.
If the Resort Fee is purchased, the items below will be included with your stay:
- Complimentary Wi-Fi (Basic Access)
- Access to Shiley Sports Complex
- Kids Eat Free from Kids Menu (12 and under) in Torreyana Grill for dinner with purchase of adult dinner entree
- In-Room Bottle Water (2 per day)
- In-Room 12oz coffee or tea (2 per day)
- Access to resort activities and events
- Breeze to the Beach City Shuttle - 2 tickets per room per day
- 20% discount for Tennis Lessons by Local Pro
- 15% Gift Shop discount
- 15% off Torrey Pines Golf Shop
Travel
Mayo Clinic School of Continuous Professional Development is not responsible for expenses incurred by an individual who is not confirmed and for whom space is not available at the meeting. Costs incurred by the registrant such as airline or hotel fees or penalties are the responsibility of the registrant.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 19.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAFP
Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.
AAPA
Mayo Clinic College of Medicine and Science has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 19.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 19.25 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
AOA
The American Osteopathic Association designates this program for a maximum of 19.25 AOA Category 2-A credits.
IPCE
This activity was planned by and for the healthcare team, and learners will receive 19.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
American Board of Surgery (ABS)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
Day | Credit(s) |
---|---|
Wednesday - Optional Pre-Course Session | 3.00 |
Thursday | 6.50 |
Friday | 5.50 |
Saturday | 4.25 |
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 19.25 AAPA Category 1
- 19.25 AMA PRA Category 1 Credit™
- 19.25 ANCC
- 19.25 AOA Category 2-A
- 19.25 Attendance
- 19.25 IPCE
On behalf of course directors Pooja P. Advani, M.B.B.S., M.D., Patricia A. Cronin, M.D., James W. Jakub, M.D., and Sandhya Pruthi, M.D., we hope you will consider a display opportunity at the Mayo Clinic Multidisciplinary Update in Breast Disease 2024 held November 6-9, 2023 at the Hilton La Jolla Torrey Pines – La Jolla, California.
Use the Exhibit Form to view the prospectus and submit your exhibit form.
Please email Karen Steele with any questions.
As a reminder, Exhibit Space availability is based on the order completed forms are submitted until space runs out. Exhibit space is not confirmed until the submitting representative is notified of their confirmation by a member of the Mayo Clinic School of Continuous Professional Development
Please update your profile to let us know if you have dietary restrictions or access requirements.
To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity. This course is not approved for on-demand delivery.
Commitment to Equity, Diversity and Inclusion
Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which individual differences are valued, allowing all to achieve their fullest potential.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.